ABSTRACT
C-reactive protein (CRP) was investigated as a marker for diagnostic screening and monitoring response to treatment for tuberculosis (TB) in Kenyan children. For screening, CRP levels did not differ significantly between children with versus without TB. However, median CRP levels decreased significantly during TB treatment in confirmed (p=0.03) and unconfirmed TB (p=0.002) suggesting potential of treatment response monitoring.
SUMMARY CRP levels did not differ significantly between children with versus without TB at diagnosis but decreased significantly during TB treatment in confirmed (p=0.02) and unconfirmed TB (p<0.001). While CRP’s diagnostic screening performance was suboptimal, findings suggest potential utility for treatment response monitoring in children with TB.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: This work was supported by the NIH/National Institute of Allergy and Infectious Diseases R01AI162152 and R01AI179714, S.M.L., NIH grant P30 AI027757; University of Washington/Fred Hutch, Center for AIDS Research (CFAR) New Investigator Award (NIA) CFAR-NIA, J.G., (AI027757); TBHTP (Tuberculosis and HIV Co-infection Training Program)- D43-TW011817, J.G. Conflicts of Interest: The authors declare no conflicts of interest
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Scientific Ethics Review Unit of Kenya Medical Research Institute gave ethical approval for this work University of Washington IRB gave ethical approval for this work University of Washington IRB gave ethical approval for this work Kenyatta National Hospital-University of Nairobi Ethics Review Committee gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data supporting the findings of this study are fully available within the manuscript and its supplementary materials
